Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTILS.L Share News (TILS)

  • There is currently no data for TILS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS SUMMARY: Tui Rises As Tips "Normal" Summer Trading

Mon, 04th Jan 2021 10:44

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.

----------

FTSE 100 - WINNERS

----------

Entain, up 26%. The gambling firm confirmed it received takeover interest from US partner MGM. Entain said the offer represents a value of 1,383 pence per share, a 22% premium to its 1,133.50p closing price on New Year's Eve. Entain shares were up 27% at 1,434.00p each on Monday morning. MGM's bid "undervalues" the company, Entain said.

----------

Polymetal International and Fresnillo, up 9.1% and 6.9%, respectively. The miners rose on the back of a rally in gold prices on Monday. An ounce of gold fetched USD1,929.22 on Monday morning, up from USD1,894.00 at the London market close on Thursday.

----------

FTSE 250 - WINNERS

----------

Tui, up 9.7%. In an interview with German publication Rheinische Post, the tour operator's executive chair, Fritz Joussen, said he expects the crucial summer period to be "relatively normal" for the travel industry due to Covid-19 vaccine rollouts.

----------

Future, up 3.1%. The media firm's GBP594 million takeover of GoCo Group - which owns Gocompare.com, Look After My Bills and MyVoucherCodes - has gained approval from the UK Financial Conduct Authority.

----------

OTHER MAIN MARKET AND AIM - WINNERS

----------

Griffin Mining, up 17%. The miner announced that its new mining licence, covering zone two and zone three of the Caijiaying mine has been approved by the Chinese Ministry of Land & Natural Resources. The new licence will allow the mining of significant additional resources.

----------

EQTEC, up 17%. The waste-to-energy firm said it has secured a GBP1.3 million unsecured term loan facility with shareholder Altair Group Investment. The 12 month facility has a 6% annual interest rate.

----------

Tiziana Life Sciences, up 9.3%. Completes clinical study of its Foralumab drug in Covid-19 patients. Topline data is expected in January, though anecdotal evidence says the drug was well-tolerated.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
27 Apr 2020 09:43

Tiziana Life Sciences files for patent on potential Covid-19 therapy

(Sharecast News) - Biotechnology company Tiziana Life Sciences has filed a provisional patent application on the combination of nanoparticle-Actinomycin D (NP-ACT D) with anti-interleukin-6 receptor monoclonal antibody (anti-IL-6R), it announced on Monday, as a potential therapy for the management of Covid-19 disease.

Read more
24 Apr 2020 18:39

Tiziana Life Sciences Acquires Potential Covid-19 Treatment Medication

Tiziana Life Sciences Acquires Potential Covid-19 Treatment Medication

Read more
9 Apr 2020 11:23

UK WINNERS & LOSERS SUMMARY: Lockdowns Lift Just Eat Takeaway Orders

UK WINNERS & LOSERS SUMMARY: Lockdowns Lift Just Eat Takeaway Orders

Read more
9 Apr 2020 09:12

Tiziana Life Sciences Shares Double On Covid-19 Treatment News

Tiziana Life Sciences Shares Double On Covid-19 Treatment News

Read more
9 Apr 2020 08:03

LONDON BRIEFING: Bank Of England Extends UK Government's Overdraft

LONDON BRIEFING: Bank Of England Extends UK Government's Overdraft

Read more
16 Mar 2020 17:48

Tiziana Raises USD10 Million To Help Fund Covid-19 Drug Development

Tiziana Raises USD10 Million To Help Fund Covid-19 Drug Development

Read more
12 Mar 2020 14:31

Tiziana Secures USD10 Million To Help Coronavirus Antibody Development

Tiziana Secures USD10 Million To Help Coronavirus Antibody Development

Read more
11 Mar 2020 12:15

Tiziana Life Sciences expediting development of Covid-19 drug

(Sharecast News) - Tiziana Life Sciences said on Wednesday that it is expediting the development of a drug that could help in the treatment of people infected with Covid-19.

Read more
11 Mar 2020 10:51

Tiziana Shares Skyrocket On Expedited Covid-19 Treatment Development

Tiziana Shares Skyrocket On Expedited Covid-19 Treatment Development

Read more
17 Feb 2020 14:30

Tiziana Life Sciences Proposes ADS Offering On Nasdaq

Tiziana Life Sciences Proposes ADS Offering On Nasdaq

Read more
4 Feb 2020 13:26

DIRECTOR DEALINGS SUMMARY: Biffa Municipal MD Sells 154,000 Shares

DIRECTOR DEALINGS SUMMARY: Biffa Municipal MD Sells 154,000 Shares

Read more
21 Jan 2020 16:09

Tiziana Life Sciences Hires OKYO Pharma Director MacRae As Non-Exec

Tiziana Life Sciences Hires OKYO Pharma Director MacRae As Non-Exec

Read more
14 Jan 2020 14:42

DIRECTOR DEALINGS: Tiziana Life Says Associate Of Chair Bought Shares

DIRECTOR DEALINGS: Tiziana Life Says Associate Of Chair Bought Shares

Read more
13 Jan 2020 11:07

Tiziana Life Science To Cancel AIM Trading Ahead Of Move To Bermuda

Tiziana Life Science To Cancel AIM Trading Ahead Of Move To Bermuda

Read more
9 Jan 2020 12:21

Tiziana Says Antibody Foralumab "Well Tolerated" At All Doses Tested

Tiziana Says Antibody Foralumab "Well Tolerated" At All Doses Tested

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.